Inova Heart and Vascular Institute – Inova Fairfax Medical Campus 3300 Gallows Rd. Falls Church, VA 22042 Located just outside of Washington, DC, in Falls Church, VA, Inova Fairfax Medical Campus is home to IHVI's dedicated heart hospital, which serves as the hub of the system's cardiac, vascular and advanced lung disease services.

Advanced Heart Failure After a Heart-Lung Transplant, a Mother Gets a Second Chance Urgent Access Heart Failure Clinics Offering Same-Day or Next-Day Appointments – Now at Three Inova Hospitals Atrial Fibrillation (AFib) Inova's Innovative Multidisciplinary Approach to AFib Care Cardiac and Respiratory Failure Cardiogenic Shock Program Continues to Achieve Outstanding Results Building a Team of Teams: Strong Collaboration Between Cardiovascular Intensive Care Units Is Associated with Great Outcomes COVID-19 Outreach Inova Targeted COVID Vaccine Hesitancy with Personal Messages from Doctors

IHVI's Critical Care Team IHVI’s 48-bed intensive care unit, divided equally between cardiac ICU (CICU) and cardiovascular ICU (CVICU), serves some of the region’s sickest patients. Over the last three years, IHVI’s critical care team has expanded its scope to meet the needs of the region, and its case-mix index has increased 3 to 3.5 times during that period. Over the last 18 months, in addition to caring for critically ill cardiac patients, the teams in CICU and CVICU have risen to the challenge of providing advanced life support for patients who are critically ill with COVID-19.

Behnam Tehrani, MD Co-Director, Cardiogenic Shock Program, IHVI Co-Director, Cardiac Catheterization Laboratories, Inova Fairfax Medical Campus Alexander Truesdell, MD Co-Director, Cardiogenic Shock Program Cardiogenic shock has long been associated with high rates of morbidity and mortality. It was not until the landmark SHOCK trial in 1999 that survival increased from 20 percent to 50 percent through early revascularization. Since then, however, no further improvements in short-term outcomes have been realized.

Inova Heart and Vascular Institute IFMC IAH IFOH ILH IMVH OFF/AMB Adult Congenital Heart Clinic X           Advanced Heart Failure Program X           Heart Failure Specialist Consults X X   X X X Heart Transplantation Medical Management X           Mechanical Circulatory Support - VAD/LVAD X           Remote Home-Based Monitoring X           Cardiac and Respiratory Failure X           Cardiogenic Shock Team X           Extracorporeal Membrane Oxygenation (ECMO) X           Impella® X     X     Pulmonary Embolism Response Team (PERT) X X   X     (Location Key) IFMC IAH IFOH ILH IMVH OFF/AMB Ca

Clinical Trial Inova Heart and Vascular Institute Explores Implant's Potential to Replace Anticoagulants in AFib Stroke Prevention Physicians at IHVI are investigating alternative solutions for AFib-related stroke prevention that reduce side effects and treatment-related costs, led by IHVI interventional cardiologist Matthew W. Sherwood, MD, MHS, Director of the IHVI LAAC/ WATCHMAN Program. Dr. Sherwood also serves as Co-Director of both the Structural Heart Program and the Cardiac Catheterization Laboratories at IFMC.

Inova's Innovative Multidisciplinary Approach to AFib Care Managing AFib and the underlying conditions that cause it is complex, with the best outcomes being achieved for patients by combining the expertise of specialists from several different medical disciplines. To further improve care for patients, Inova’s AFib Center was created and follows the multidisciplinary "center of excellence" model recently published by the Heart Rhythm Society.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare condition of high blood pressure in the lungs’ arteries caused by blood clots that narrow and limit the blood flow to the lungs. It causes shortness of breath and may be a consequence of acute pulmonary emboli, but it can also present without prior diagnosis of pulmonary emboli. Radiographic images show a 75-year-old man with lifestyle limiting CTEPH who underwent balloon pulmonary angioplasty (BPA). Left A8 segment is shown pre- and post-BPA procedure.

Four Northern Virginia Locations for Comprehensive Wound Treatment Chronic nonhealing wounds – those that do not progress through the healing stages in a predictable and timely manner – can cause serious problems such as chronic pain, loss of function, decreased mobility, and increased isolation and stress. Today, about 6.5 million Americans are suffering with chronic nonhealing wounds, and this number is projected to increase as the United States population gets older.